Godshalk Welsh Capital Management’s Gilead Sciences GILD Stock Holding History

Godshalk Welsh Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,500	Closed	-$203K	–	126
2017 Q3	$203K	Buy	+2,500	New	+$191K	0.2%	125
2016 Q2	–	Sell	-2,400	Closed	-$220K	–	130
2016 Q1	$220K	Buy	2,400 +150	+7%	+$13.5K	0.23%	127
2015 Q4	$228K	Hold	2,250	–	–	0.24%	125
2015 Q3	$221K	Hold	2,250	–	–	0.24%	128
2015 Q2	$263K	Sell	2,250 -250	-10%	-$27.3K	0.27%	122
2015 Q1	$245K	Sell	2,500 -1,000	-29%	-$102K	0.25%	118
2014 Q4	$330K	Buy	+3,500	New	+$362K	0.3%	110

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Godshalk Welsh Capital Management's GILD Position: Q4 2017 in Review

Godshalk Welsh Capital Management sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 2,500 shares — an estimated $203K sold.

Godshalk Welsh Capital Management first reported a position in GILD in Q4 2014 and held it in 7 quarters. The position peaked at $330K in Q4 2014. 1,575 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

Godshalk Welsh Capital Management reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
Godshalk Welsh Capital Management sold 2,500 Gilead Sciences shares in Q4 2017, an estimated $203K.
Godshalk Welsh Capital Management first reported a position in Gilead Sciences in Q4 2014 and held it in 7 quarters.
Godshalk Welsh Capital Management's Gilead Sciences position peaked at $330K in Q4 2014.
1,575 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Godshalk Welsh Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.